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Abstract
Background: With the current rise in obesity-related morbidities, real-time quantitative reverse transcription polymerase
chain reaction (qRT-PCR) has become a widely used method for assessment of genes expressed and regulated by
adipocytes. In order to measure accurate changes in relative gene expression and monitor intersample variability,
normalization to endogenous control genes that do not change in relative expression is commonly used with qRT-PCR
determinations. However, historical evidence has clearly demonstrated that the expression profiles of traditional control
genes (e.g., b-actin, GAPDH, a-tubulin) are differentially regulated across multiple tissue types and experimental conditions.
Methodology/Principal Findings: Therefore, we validated six commonly used endogenous control genes under diverse
experimental conditions of inflammatory stress, oxidative stress, synchronous cell cycle progression and cellular
differentiation in 3T3-L1 adipocytes using TaqMan qRT-PCR. Under each study condition, we further evaluated the impact
of reference gene selection on experimental outcome using examples of target genes relevant to adipocyte function and
differentiation. We demonstrate that multiple reference genes are regulated in a condition-specific manner that is not
suitable for use in target gene normalization.
Conclusion/Significance: Data are presented demonstrating that inappropriate reference gene selection can have profound
influence on study conclusions ranging from divergent statistical outcome to inaccurate data interpretation of significant
magnitude. This study validated the use of endogenous controls in 3T3-L1 adipocytes and highlights the impact of
inappropriate reference gene selection on data interpretation and study conclusions.
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Introduction
The obesity epidemic has led to a plethora of investigations
examining mechanisms that regulate adipocyte differentiation and
function as well as the role adipose tissue plays in the development
of insulin resistance, diabetes and heart disease. As our
understanding of the adipocyte has progressed from that of a
storage depot to an endocrine cell, there is increased need to
examine relative expression of low-abundance genes (e.g.,
cytokines, adipokines) involved in metabolic regulation from a
tissue that traditionally yields limited RNA [1–4]. While earlier
work with conventional methodology provided qualitative assess-
ment of mRNA abundance, the quantitative nature of real time
qRT-PCR affords a measure of sensitivity that is suited for reliable
detection of 2-fold changes in gene expression over dynamic
ranges of starting material [2,5]. This methodology comes with a
price, however, as increased sensitivity of qRT-PCR along with
inherent variability in biological systems, experimental and
extraction protocol disparity, as well as differences in reverse
transcription and PCR efficiencies makes normalization of real-
time data an absolute requirement for accurate data interpretation
regarding genes of interest [5–8].
Several strategies have been proposed for normalization of
qRT-PCR data, the most common of which involves analysis of a
co-expressed endogenous control (i.e., reference gene) whose
relative expression should not change with treatment or study
conditions [5,7,9]. When these criteria are strictly met, this
strategy would be expected to ‘normalize’ confounding variation
due to intersample variability such as differences in PCR efficiency
or loading disparity. b-actin, glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) and a-tubulin have been traditionally used as
control, ‘house-keeping’ genes for Northern blotting and other
conventional, less sensitive assays, in spite of decades of reports
clearly demonstrating expression profiles that vary markedly based
on cellular phenotype and experimental design [10–12]. While
some reports contend that overall study conclusions would remain
the same as the variability in a reference gene would be similar
between study and control groups [13], others note that
normalization to an inappropriate endogenous control may lead
to misinterpretation and confounding data with qRT-PCR
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reference gene expression under various experimental conditions
[2,4,15], few have explored the impact of reference gene selection
on data interpretation and study conclusions [14].
To evaluate the impact of reference gene selection on experimental
outcome, we validated six commonly used reference genes including
GAPDH, b-actin, transferrin receptor (TfR), cyclophilin A (cyc), a-
tubulin (a-tub) and 18 ribosomal RNA (18S) using TaqMan qRT-
PCR chemistry and methodology in the well-established 3T3-L1
adipocyte cell line under four diverse study conditions including
inflammatory stress, oxidative stress, synchronous cell cycle progres-
sionand cellulardifferentiation.Under each study condition, data are
presented demonstrating the impact of reference gene selection on
normalized target gene expression. This report clearly demonstrates
the critical importance of reference gene validation for all
experimental conditions regarding significance, interpretation, and
experimental outcome when using the sensitivity and reliability of
qRT-PCR for assessment of relative gene expression.
Results
Effect of small variation in reference gene expression on
statistical significance
A widely used method of correcting for intersample variability
using qRT-PCR involves normalizing to one or more reference
genes whose expression should not change with treatment or
between study conditions [5,7,9]. Thus, it is important to
distinguish technical variability from true biological changes in
gene expression. For this purpose, we chose to use guidelines
previously described by Gorzelniak et al [2], whereby reference
genes are classified based on treated and untreated differences in
cycle number when an amplified probe crosses the threshold
(DCT) during qRT-PCR reactions. According to these guidelines,
DCT values # +/20.5 are considered fluctuation in gene
expression that is largely due to technical variance (e.g., unequal
loading, PCR efficiency, etc.) that should be reflected similarly
between both reference and target genes. Conversely, DCT values
$ +/21.0 are strongly suggestive of biological variability resulting
from treatment or study conditions, precluding the use of such
reference genes for target gene normalization. To gain insight into
DCT values that fall between 0.5 and 1.0, we extended the
guideline by observing reference gene expression over time
following treatment for consistent direction shifts between
contiguous data points that would be suggestive of biological
variance.
Using the criterion of DCT # +/20.5 as a delimiter of reference
gene suitability, we evaluated six commonly used reference genes
(Table 1) over time in undifferentiated 3T3-L1 preadipocytes
following exposure to either 1 nM TNFa or 300 mMH 2O2,
representing conditions of inflammatory and oxidative stress,
respectively. As DCT values are exponents and should not be
statistically evaluated [16], all validation data were converted to
‘fold-changes’ using the 2
2DC
T method for raw data or 2
2DDC
T
method for normalized data. Accordingly, DCT of +0.5 and 20.5
is equivalent to 0.7 and 1.4 fold changes in relative gene
expression, respectively. As illustrated in Fig. 1A, relative
expression of most (5 of 6) reference genes tested (a-tub, cyc,
TfR, GAPDH and 18S) fluctuated within the DCT # +/20.5
limits in a manner that would be consistent with intersample
variability and, thus, considered suitable for use in target gene
normalization following TNFa exposure. In contrast,b-actin
steadily and consistently dropped below the DCT # +/20.5 at
all time points following 3 hrs post-TNFa stimulation (Fig. 1B). As
the DCT for b-actin closely approximated a value of 1.0 (i.e., 0.5-
fold decrease) at contiguous time points, these changes were likely
due to biological variability, thus precluding this commonly used
reference gene for suitability under these experimental conditions.
To assess the impact of using b-actin as a reference gene, we
examined relative expression of dual specificity phosphatase-10
(Dusp10) without and with normalization to either 18S, the
geometric mean of three stable reference genes (a-tub, TfR,
GAPDH) or b-actin following TNFa exposure. Dusp10 was
chosen for this experiment as a gene that is not responsive to
TNFa stimulation under these conditions. As illustrated in Fig. 1D,
fold changes in Dusp10 gene expression when normalized to 18S
or the geometric mean of three reference genes closely
approximated fold changes as shown for raw Dusp10 without
normalization (Fig. 1C), where data points following treatment
were not significantly different from untreated controls. In
contrast, when Dusp10 was normalized to b-actin, each point
where b-actin fell outside the DCT # +/20.5 delimiter range was
significantly different from untreated controls. Thus, normalizing
Table 1. TaqMan primer probes used for this study.
symbol gene name accession manufacturer’s no length CT
reference genes
Actb b-actin NM_007393.3 Mm00607939_s1 115 17
Gapdh glyceraldehyde-3-phosphate dehydrogenase (GAPDH) NM_008084.2 Mm99999915_g1 107 17
Tuba1a a-tubulin (a-tub) NM_011653.2 Mm00846967_g1 123 23
Ppia peptidylprolyl isomerase A (cyclophilin A (cyc)) NM_008907.1 Mm02342430_g1 148 17
Tfrc transferrin receptor (TfR) NM_011638.3 Mm00441941_m1 66 26
18S 18 ribosomal RNA X03205.1 4342930E 187 9
target genes
Dusp3 dual specificity phosphatase-3 NM_028207.2 Mm00459216_m1 59 26
Dusp10 dual specificity phosphatase-10 NM_022019.5 Mm00517678_m1 104 26
Cebpb CAATT/enhancer binding protein beta (C/EBPb) NM_009883.3 Mm00843434_s1 159 25
Ccna2 cyclin A2 NM_009828.2 Mm00438064_m1 90 23
Pparg peroxisome proliferator activator receptor c (PPARc) NM_001127330.1 Mm00440945_m1 105 25
doi:10.1371/journal.pone.0015208.t001
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that did not occur with 18S or the geometric mean of stable
reference genes.
Similar implications regarding inappropriate reference gene
selection were observed under conditions of oxidative stress. As
shown in Fig. 2B, b-actin and TfR were the only two reference
genes that increased steadily above DCT # +/20.5 range at more
than one contiguous time point. To assess the impact of reference
gene selection, we examined relative changes in Dusp3 gene
expression without and with normalization to either 18S, the
geometric mean of three reference genes (GAPDH, cyc, a-tub) or
b-actin following H2O2 exposure. Dusp3 was chosen for this
experiment as a gene that displays modest (,3 fold), but significant
increases in response to H2O2 stimulation. When Dusp3 was
normalized to 18S or the geometric mean of stable reference genes
(Fig. 2D), fold changes closely approximated those shown for raw
Dusp3 without normalization (Fig. 2C), where gene expression was
significantly different from untreated controls at each point
following 3 hrs post-H2O2 exposure. When Dusp3 was normalized
to b-actin, however, the target gene was no longer significantly
different from untreated controls at any point where this reference
gene fell outside the DCT # +/20.5 range of suitability. Thus,
normalizing Dusp3 to b-actin under conditions of oxidative stress
resulted in an inaccurate ‘loss’ of significance that did not occur
with 18S or the geometric mean of stable reference genes.
Collectively, these data demonstrate that statistical significance is
highly dependent on appropriate reference gene selection, even
when changes in reference gene expression are marginal.
Effect of large variation in reference gene expression on
experimental outcome
To examine the impact of considerable reference gene
variability on target gene expression, we validated the same six
reference genes during diverse experimental conditions of
proliferation and differentiation, both of which have been known
Figure 1. Gain of statistical significance with inappropriate reference gene selection. Total RNA was isolated over time from density-
arrested 3T3-L1 preadipocytes treated with 1 nM TNFa and assessed for reference and target gene expression by qRT-PCR. Fold changes in reference
genes that fell within (A) and outside (B) the DCT # +/20.5 limits of suitability. Fold changes in Dusp10 gene expression without (C) and with
normalization (D) to 18S, the geometric mean of three reference genes or b-actin. Asterisks indicates significant differences between treated and
untreated samples (p,0.05).
doi:10.1371/journal.pone.0015208.g001
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reference genes [11,12]. Early stages of 3T3-L1 adipocyte
differentiation are characterized by synchronous cell cycle
progression [17,18], where quiescent preadipocytes cycle through
one complete round of cell division within 24 hrs post-MDI
concurrent with the onset of early stages of adipocyte gene
expression [19,20]. As shown in Fig. 3A, 18S was the only
reference control that did not fluctuate beyond the DCT # +/
20.5 range of suitability at any time point during the first 24 hrs of
adipocyte differentiation. In contrast, most (4 of 6) of the reference
genes were disqualified as appropriate reference controls based on
fold changes that exceeded this range at more than one contiguous
time point with GAPDH and TfR displaying marked increases
(.4-fold) clearly indicative of biological variability. Cyclophilin A
expression fell outside the delimiter range only at the 24 hr time
point with a 2-fold increase in gene expression (Fig. 3B).
To assess the impact of reference gene selection under these
conditions, we evaluated two unrelated target genes with well-
established roles during this early phase of adipocyte differentia-
tion. First, we examined the expression profile of the transcription
factor, C/EBPb, which is known for its role in initiating a cascade
of transcriptional events that culminate in acquisition of the
mature adipocyte phenotype [21–25]. Normalization of C/EBPb
to 18S resulted in fold changes in gene expression (Fig. 3D) that
were nearly identical to fold changes in raw expression without
normalization (Fig. 3C) where 2 hrs post-MDI yielded 9-fold
induction in target gene expression that decreased to 4-fold
induction by 6 hrs where it remained consistently and steadily
elevated for 24 hrs. These results were very similar to the well-
documented expression profile of C/EBPb using conventional
methodology and consistent with its role in regulating the
expression of C/EBPa and PPARc, two master regulators of
adipogenesis that are induced ,48 hrs into differentiation [25,26].
In contrast, however, the prolonged increase in gene expression
beyond 6 hrs post-MDI was not evident when C/EBPb was
normalized to TfR, where the 6-fold induction of the reference
Figure 2. Loss of statistical significance with inappropriate reference gene selection. Total RNA was isolated over time from density-
arrested 3T3-L1 preadipocytes treated with 300 mMH 2O2 and assessed for reference and target gene expression by qRT-PCR. Fold changes in
reference genes that fell within (A) and outside (B) the DCT # +/20.5 limits of suitability. Fold changes in Dusp3 gene expression without (C) and with
normalization (D) to 18S, the geometric mean of three reference genes, or b-actin. Asterisks indicates significant differences between treated and
untreated samples (p,0.05).
doi:10.1371/journal.pone.0015208.g002
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from density-arrested 3T3-L1 preadipocytes treated with MDI and assessed for reference and target gene expression by qRT-PCR during early stages
of differentiation. Fold changes in reference genes that fell within (A) and outside (B) the DCT # +/20.5 limits of suitability. Fold changes in C/EBPb
gene expression without (C) and with normalization (D) to 18S, cyc, or TfR. Fold changes in cyclin A gene expression without (E) and with
normalization (F) to 18S, cyc, or TfR.
doi:10.1371/journal.pone.0015208.g003
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did not identify three stable reference genes that could be grouped
in a geometric mean, we further normalized C/EBPb to
cyclophilin A that fell outside the DCT # +/20.5 range of
suitability only at the 24 hr time point. As shown in Fig. 3D, C/
EBPb normalized to cyclophilin A resulted in fold changes that
closely approximated both raw C/EBPb as well as that normalized
to 18S at all time points where this reference gene fell within the
DCT # +/20.5 limits. However, the two-fold increase in
cyclophilin at 24 hrs post-MDI resulted in a 50% reduction of
target gene expression at that time point.
We next evaluated the expression profile of cyclin A, which is
well known for its regulatory role during S phase of proliferation
[27,28] where mRNA has been shown to be elevated between
16 hrs and 30 hrs post-MDI [26]. Similarly, the expression profile
was nearly identical when comparing raw cyclin A expression
(Fig. 3E) to that which was normalized to 18S (Fig. 3F), where
expression initially decreased below baseline levels before
increasing to a 3-fold induction by 24 hrs. When the same target
gene was normalized to TfR instead, the .4-fold increase in TfR
at 6 hrs post-MDI resulted in a dramatic drop in cyclin A
expression that never increased above untreated basal levels
throughout the course of cell cycle progression (Fig. 3F). We also
normalized cyclin A to cyclophilin A as discussed above where the
expression profile approximated that observed for raw cyclin A as
well as cyclin A normalized to 18S, at all time points where
cyclophilin fluctuated within the DCT # +/20.5 range of
suitability. However, at the one time point where cyclophilin
exceeded that range, the 3-fold increase in cyclin A was
erroneously ablated by the 2-fold increase in cyclophilin
expression.
We further evaluated reference gene selection over the entire
course of differentiation (0–10 days post-MDI) where 18S was
again the only reference control examined that fluctuated clearly
within our DCT # +/20.5 range of suitability (Fig. 4A). Under
these conditions, most (4 of 6) reference genes tested were
disqualified as suitable reference genes as expression exceeded the
delimiter range at more than one contiguous time point with TfR
and GAPDH displaying marked increases and a-tubulin marked
decreases in relative expression clearly indicative of biological
variability. Cyclophilin A fluctuated beyond the DCT # +/20.5
range only at 24 hrs post-MDI. To illustrate the impact of
reference gene selection under these conditions, we examined the
expression profile of a single target gene individually normalized to
five different reference genes of varying degrees of suitability. For
this study, we chose the transcription factor, PPARc, whose
function is well-established as a dominant transcriptional regulator
of adipogenesis [29–31]. As expected, expression profiles were
nearly identical, by kinetics and magnitude, when comparing raw
PPARc expression (Fig. 4C) to that which was normalized to 18S
(Fig. 4D), where expression gradually increased from 2 days post-
MDI reaching a plateau at 8 days post-MDI with a 40-fold
induction in gene expression. As cyclophilin A fell outside the DCT
# +/20.5 range only at one time point prior to the induction of
PPARc, we noted little deviation in magnitude or kinetics when
comparing PPARc normalized to cyclophilin A versus 18S. In
contrast, the magnitude of PPARc expression was dramatically
attenuated when normalized to TfR as compared to 18S reaching
only a 10-fold increase in gene expression (Fig. 4D). Conversely,
the magnitude of PPARc expression was dramatically increased
when normalized to a-tubulin reaching nearly a 350-fold increase
in gene expression at 6 days post-MDI (Fig. 4E). Although end
point magnitude was nearly identical, normalizing PPARc to
GAPDH resulted in a dramatic delay in the kinetics of PPARc
mRNA accumulation as compared to 18S (Fig. 4F). Collectively,
these data demonstrate that reference gene selection can have a
profound impact on experimental outcome illustrating the critical
need to validate each reference gene in a cell-type and condition-
specific manner.
Discussion
Our report presents empirical evidence demonstrating that
inappropriate reference gene selection for qRT-PCR normaliza-
tion can have profound influence on study conclusions ranging
from divergent statistical outcome to inaccurate data interpreta-
tion of significant magnitude. First, we demonstrate that many
commonly used reference genes fluctuate in a condition-specific
manner beyond the limits of suitability when normalizing for
target gene expression using qRT-PCR. Second, we illustrate that
even small variability in reference gene expression can have a
marked influence on the presence or absence of statistical
significance between study groups, especially when target genes
show modest changes in mRNA abundance. Third, this report
demonstrates that improper selection of a suitable reference gene
can lead to grossly inaccurate data that would significantly affect
interpretation of biological outcome and study conclusions. These
data collectively demonstrate that validation of each reference
gene on an individual basis for all treatment and experimental
conditions is paramount for accurate data interpretation when
normalizing for intersample variability involving qRT-PCR.
Data presented here and elsewhere [14] clearly demonstrate
that whether statistically significant differences between study
groups are present or absent can depend on which reference gene
is used for normalization even when variability in reference gene
expression is marginal. Comparing the outcome of normalizing to
b-actin versus 18S, we present data from two genes; Dusp10 whose
raw profile did not vary over time following TNFa (Fig. 1) and
Dusp3 that increased following H2O2 with statistical significance.
Neither the expression profile nor significance in gene expression
of either gene was markedly influenced by normalizing to 18S or
the geometric mean of three stable reference genes. In contrast,
normalizing Dusp10 and Dusp3 to b-actin resulted in an
inaccurate gain or loss of significance, respectively, demonstrating
that even small, less than 2-fold variation in reference gene
expression can have a significant influence on statistical outcome.
Both experiments presented evidence of biological variability as b-
actin expression approached 2-fold differences between treated
and untreated conditions at contiguous time points following
stimulation strongly implicating the effect of experimental
treatment on relative gene expression. It is also interesting to note
that these changes in reference gene expression had a discernible
impact on significance at all time points where b-actin exceeded
the DCT # +/20.5 range of suitability. Whether or not the
variability of b-actin under these experimental conditions was
representative of true biological change in gene expression can be
argued, these data clearly demonstrate that careful reference gene
validation is critical when considering statistical significance of
target genes, especially those that present with marginal changes in
gene expression.
This investigation further demonstrates that grossly inaccurate
conclusions can result from studies where reference genes show
marked differences in mRNA abundance that clearly result from
treatment or study conditions. Comparing the outcome of
normalizing to a variety of conventionally used reference genes
that presented with indisputable biological variability, we
presented data from two experiments involving three target genes
with well-defined roles in adipocyte differentiation where reference
Reference Gene Selection and Experimental Outcome
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10 days) from density-arrested 3T3-L1 preadipocytes treated with MDI and assessed for reference and target gene expression by qRT-PCR during
complete adipocyte differentiation. Fold changes in reference genes that fell within (A) and outside (B) the DCT # +/20.5 limits of suitability. Fold
changes in PPARc gene expression without (C) and with normalization to 18S, cyc, or TfR (D), 18S, cyc, or a-tubulin (E), and 18S, cyc, or GAPDH (F).
Arrows indicate directional shifts relative to normalization to 18S.
doi:10.1371/journal.pone.0015208.g004
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The first of these experiments (Fig. 3) examined the expression
profile of C/EBPb and cyclin A during the first 24 hrs of
differentiation, which is known to include a phase of synchronous
cell cycle progression. While the expression profile of either gene
was not markedly influenced when normalizing to 18S, the well-
documented prolonged expression of C/EBPb during this time
period as well as the induction of cyclin A at 24 hrs required for S
phase progression was completely ablated when normalizing to
TfR that presented with its own 6-fold increase in gene expression.
Simply normalizing to this conventionally used reference gene
without validation would have resulted in grossly inaccurate data
as the outcome would have been that the expression of both genes
decreased, rather than increased, relative to unstimulated basal
expression at 24 hrs of differentiation. Similar impact on
experimental outcome was also noted in the second experiment
(Fig. 4) where PPARc expression was individually normalized to a
variety of reference genes over the entire course of differentiation.
While the expression profile was not markedly influenced when
normalized to 18S, the well-documented induction of this target
gene was markedly suppressed when normalized to TfR, increased
when normalized to a-tub, and delayed when normalized to
GAPDH. In this example, normalizing to inappropriate reference
genes markedly altered both kinetics and magnitude of target gene
expression to an extent that would unquestionably lead to
erroneous data interpretation and study conclusions.
Based on the unequivocal impact of reference gene selection on
experimental outcome presented here and elsewhere [14], there is
a clear need for guidelines concerning tolerable variability of
reference genes used for data normalization [32]. In this report, we
chose a criterion defined by others [2] that quantifies changes in
CT values of a given reference gene between treated and untreated
conditions. We extended the original criterion by examining
changes in CT values over time following treatment so as to
determine whether modest fluctuations presented with sporadic
directional swings consistent with ‘noise’ as opposed to trends in
contiguous data points consistent with biological effects on gene
expression. This extension was considered particularly valuable
when evaluating changes in CT values between 0.5 and 1.0 as
shown here for b-actin where the biological trend in reference
gene expression resulted in the erroneous gain or loss of statistical
significance regarding genes of interest. As qRT-PCR protocols
have been refined, it has become well-established that changes in
CT values $ 1.0, representing $ 2-fold changes in gene expression
are most likely due to biological variance [2] and ABI (P/N
4371001 Rev A). Thus, reference genes that present with DCT
values $ 1.0 should not be used for normalization, if indeed the
observed changes in gene expression are due to biological versus
technical variance, which may be difficult to discern in some
circumstances. Arguably, use of reference genes that display 2-fold
changes in gene expression could serve the purpose of normali-
zation, but only if the variance is technical in nature requiring
additional measures (e.g., evaluation over time, etc) to establish
suitability when using a single reference gene.
To address these concerns, others have proposed normalizing
target gene expression to the geometric mean of three stable
reference genes [33]. While equivalent directional shifts among
three reference genes would be strongly indicative of technical
variation supporting the use of DCT values exceeding 1.0, this
method of normalization, which would be reagent and labor
expensive, would still require validation to identify three references
genes that do not display indices of biological variance as marked
deviation of even a single gene could significantly affect the
geometric mean of multiple genes resulting in erroneous data
interpretation. In some circumstances, the added expense may not
be necessary as shown here and by others [34], where
experimental outcome using a single, stable reference gene was
equivalent to that observed when using the geometric mean of
multiple, stable reference genes. It may also be necessary to
validate more than three reference genes in order to identify at
least three that are not affected by biological variance as shown in
this report where validation of as many as six reference genes
during adipocyte differentiation failed to identify three reference
genes that displayed stable expression suitable for inclusion in
geometric mean analyses. Therefore, it is imperative that all
reference genes are validated for each experimental condition
regardless of whether a single reference gene or the geometric
mean of multiple reference genes is the chosen method of
normalization. This premise should apply even when using
established algorithms that quantify gene stability [4] as variation
between tissue and cell type or experimental treatment may lead to
biological changes in gene expression that is otherwise stable or at
least unaffected by biological variance.
Albeit normalizing target gene expression to one or more
reference genes is the method of choice of many investigators
[5,16], it is important to note that some situations may warrant the
evaluation of raw target gene expression that is not corrected for
technical variance. As reference gene validation presents with its
own set of difficulties, others have also proposed normalizing
target gene expression to total RNA [6,35]. However, neither
method corrects for technical variation imposed by pipetting error,
differences in PCR efficiency, or reaction interference imposed by
contaminating reagents such as salts and phenol. It remains a
matter of debate as to which method results in the most accurate
experimental outcome. As one size may not fit all, any given
technique may represent the best approach for a given set of
circumstances or experimental conditions leaving the investigator
to evaluate each method as warranted by the specific experiment
under investigation.
Validation criteria used in this report demonstrated that 18S
rRNA presented with the least degree of fluctuation of the six
endogenous controls tested with DCT # +/20.5 under four
diverse experimental conditions. While 18S has been reported as
the most stable endogenous control under various experimental
conditions [15,36], including omental and subcutaneous adipose
tissues from obese and diabetic patients [15], others have noted
modest variability in 18S following hormonal challenge of cultured
human adipocytes [2]. Furthermore, 18S has been reported as the
most unstable of endogenous controls tested in human visceral
adipose tissue using various algorithms that quantify gene stability
[4]. Interestingly, the latter report also demonstrated b-actin and
GAPDH as among the most stable of reference genes tested under
their defined experimental conditions. Although validated by
different criteria, we do not find these reports contradictory as the
results are specific for the experimental conditions under
investigation. More to our point, we feel the diversity of these
reports suggest the critical importance of validating all reference
genes under all experimental conditions by all investigators. Even
in our report, conventionally used reference genes such as
GAPDH, a-tub, and TfR that were suitable under one condition,
were deemed highly inappropriate for another condition in the
same cell type. The blind use of any reference gene, including 18S
rRNA, simply because it is commonly reported in the literature
should not be the reason for selection of any control when
normalizing target gene expression as measured by qRT-PCR.
While our studies highlighted 18S as the most stable of
endogenous controls under all four of our defined experimental
conditions, it should be noted that there are concerns with using
Reference Gene Selection and Experimental Outcome
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machinery in a matter similar to mRNA [15,37]. Moreover, there
are some [37] that question whether 18S represents the best
reference control when normalizing a low abundance target gene
that crosses the threshold at 24 cycles relative to the very abundant
18S with a CT value of 9 cycles (Table 1), corresponding to a
32,000 fold-difference in gene expression. To address these
concerns, we determined that 18S was linear from 50 ng to 5 pg
in our TaqMan assay and that the slope was nearly identical to
those from calibration curves generated for each target gene (data
not shown). Furthermore, we observed no differences in relative
target gene expression when normalized to undiluted 18S at 50ng
compared to diluted 18S at 50 pg, representing a 10 cycle
difference in CT value. While these data support the use of 18S as
a suitable control for normalization, it should not be inferred that
it was the only valid control in our study, nor should it be used
without validation under each experimental condition.
In summary, we validated six commonly used reference genes
for the purpose of evaluating the impact of reference gene selection
on normalization of five target genes under diverse experimental
conditions relevant to adipocyte biology. Data are presented
demonstrating that inappropriate reference gene selection can
have profound influence on study conclusions ranging from
divergent statistical outcome to inaccurate data interpretation of
significant magnitude. As all reference genes will likely fluctuate to
unacceptable degrees of variability in one condition or another,
data presented here strongly caution against the blind use of any
endogenous control that has not been validated specifically for the
experimental conditions under study. Use of unvalidated controls
has lead to flawed outcomes where reported changes in target gene
expression were actually due to changes in reference gene
expression [5,7,38]. Until reference genes are evaluated on an
individual basis for all experimental conditions, the erroneous
impact of inappropriate reference gene selection on data
interpretation and biological outcome will undoubtedly continue
to contribute to inaccurate study conclusions and inconsistencies
between reports.
Materials and Methods
Cell Culture and Differentiation Protocol
Murine 3T3-L1 preadipocytes, obtained from Howard Green,
Harvard Medical School [39], were induced to differentiate as
previously described [17]. Briefly, cells were propagated in growth
medium containing DMEM supplemented with 10% calf bovine
serum until reaching density-arrest at 2 days post-confluence. For
partial determinations, total RNA was harvested over time from
density-arrested preadipocytes treated with 1 nM TNFa or
300 mMH 2O2 representing conditions of inflammatory or
oxidative stress, respectively. For other determinations, density-
arrested preadipocytes were induced to differentiate with a
hormonal cocktail containing DMEM supplemented 10% fetal
bovine serum (FBS), 0.5 mM, 1-methyl-3-isobutylxanthine, 1 mM
dexamethasone, and 1.7 mM insulin (MDI). After 2 days, culture
medium was changed to DMEM supplemented only with 10%
FBS. As it is well-documented that this adipocyte cell line
synchronously reenters the cell cycle for 1–2 rounds of cell
division prior to the onset of adipocyte gene expression [18,26],
total RNA was harvested over time following MDI for a period of
24 hrs that has been shown to encompass one cell cycle [19,20].
For differentiation determinations, total RNA was harvested from
preadipocytes induced to differentiate at 2 day intervals over 10
days which is sufficient time for conversion of density-arrested
preadipocytes to fully mature adipocytes [25,26].
Real-time RT-PCR
Total RNA was extracted and genomic DNA contamination
was removed using the RNeasy Plus Mini Kit (Qiagen) following
the manufacturer’s protocol and total RNA was quantified with a
Nanodrop ND-1000 spectrophotometer. Total RNA (2 mg) was
reverse-transcribed to cDNA in a 20 ml reaction volume using a
high capacity cDNA reverse transcription kit (Applied Biosystems).
The reverse transcription (RT) master mix containing RT buffer,
dNTP mix, RT random primers, RNase inhibitor (1.0 U/ml), and
MultiScribe RT was added to 2 mg RNA and RNase-free water.
Reverse transcription reaction conditions followed the protocol
(hold at 25uC for 10 minutes, hold at 37uC for 120 minutes, hold
at 85uC for 5 seconds, followed by 4uC indefinitely/RT complete)
and utilized the Gene Amp PCR System 9700 thermal cycler
(Applied Biosystems) for cDNA synthesis.
PCR amplification was run utilizing the 7500 fast system
(Applied Biosystems) that consisted of enzyme activation at 95uC
for 20 seconds, followed by 40 cycles of denaturation at 95uC for 3
seconds combined with annealing/extension at 60uC for 30
seconds. All data were analyzed with the ABI 7500 real time PCR
system (Applied Biosystems). TaqMan primer probes (Table 1)
were purchased from Applied Biosystems. Data were recorded and
analyzed with Sequence Detector Software (Applied Biosystems)
and graphs visualized with SigmaPlot software. All data are
representative of experiments performed at least three times in
duplicate. Data are mean 6 standard error of the mean (SEM).
Relative differences between treated and untreated control
samples were analyzed by Student’s t-test where a p-value of
,0.05 was considered statistically significant.
Validation of endogenous controls was measured as the difference
in threshold cycle number (DCT) between treatment and control
and converted to fold changes as previously described [16].
Utilizing the DCT method, a one cycle difference correlates to a 2-
fold increase or decrease of mRNA. Normalization of target gene to
reference gene used the 2
2DDC
T method, where DDCT =( C T,target –
CT,reference) treated sample –( C T,target –C T,reference) untreated sample.
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